Tugenumon 5/8 milligrams

Adult dose

Candesartan cilexetil - Essential hypertension: The initial and maintenance dose is recommended as 8–16 mg orally once daily, and if blood pressure is not controlled after 4 weeks of 16 mg treatment, it may be increased up to a maximum of 32 mg. - Heart failure: The initial dose is recommended as 4 mg orally once daily, and the dose may be doubled at intervals of more than 2 weeks up to a maximum of 32 mg. Rosuvastatin - Primary hypercholesterolemia, etc.: The initial dose is 5 mg once daily.

Child dose

The safety and efficacy in children and adolescents under 18 years have not been established, therefore use is not recommended.

This medication can cause serious harm to the fetus and newborn, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to this medication, severe liver dysfunction, women who are pregnant or breastfeeding, and patients with certain kidney diseases. Elderly patients, patients with high serum potassium levels, and those with weakened liver or kidney function should use this medication cautiously and require regular examinations. If muscle pain, muscle weakness, or unusual muscle symptoms occur while taking this medication, consult a doctor immediately, and if necessary, a blood test should be conducted to check for muscle damage. If liver dysfunction is suspected, the use of this medication should also be discontinued and a doctor's opinion sought, with regular testing of liver enzyme levels recommended. This medication may interact with other drugs, so it is essential to inform healthcare providers of any other medications being taken, especially when used concurrently with potassium-sparing diuretics or certain antibiotics and antifungals. Women who are pregnant or planning to become pregnant should consult with healthcare providers before taking this medication and use appropriate contraceptive methods. The safety and efficacy in children and adolescents have not been established, so this medication should not be used in these populations. In cases of overdose, seek medical attention promptly for appropriate treatment, as symptoms such as hypotension or dizziness may occur. During treatment, rapid drops in blood pressure may happen, so caution is needed when driving or operating machinery. Keep this medication out of the reach of children, and do not transfer medications to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling of skin, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attack, respiratory issues accompanied by cough and fever, yellowing of skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, coma

Mild side effects

• Headache
• dizziness
• nasopharyngitis
• local infection
• periodontitis
• itching
• arthralgia
• limb pain
• glare
• dyspepsia

This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 to 30 degrees Celsius.

Appearance

Pink round film-coated tablet

Package unit

30 tablets (10 tablets/PTP x 3)